CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway
Article in Functional & Integrative Genomics (January 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours
Article in PLOS ONE (October 2023)
Regulation of programmed death ligand 1 expression by interferon‐γ and tumour necrosis factor‐α in canine tumour cell lines
Article in Veterinary and Comparative Oncology (March 2023)